{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,16]],"date-time":"2026-01-16T08:02:03Z","timestamp":1768550523766,"version":"3.49.0"},"reference-count":80,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2010,2,1]],"date-time":"2010-02-01T00:00:00Z","timestamp":1264982400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Medical Hypotheses"],"published-print":{"date-parts":[[2010,2]]},"DOI":"10.1016\/j.mehy.2009.09.003","type":"journal-article","created":{"date-parts":[[2009,9,28]],"date-time":"2009-09-28T08:09:25Z","timestamp":1254125365000},"page":"297-300","source":"Crossref","is-referenced-by-count":21,"title":["Promiscuous modulation of ion channels by anti-psychotic and anti-dementia medications"],"prefix":"10.1016","volume":"74","author":[{"given":"Matt T.","family":"Bianchi","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"4","key":"10.1016\/j.mehy.2009.09.003_bib1","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1016\/j.tips.2005.02.007","article-title":"The efficiency of multi-target drugs: the network approach might help drug design","volume":"26","author":"Csermely","year":"2005","journal-title":"Trends Pharmacol Sci"},{"issue":"10","key":"10.1016\/j.mehy.2009.09.003_bib2","doi-asserted-by":"crossref","first-page":"1110","DOI":"10.1038\/nbt1007-1110","article-title":"Network pharmacology","volume":"25","author":"Hopkins","year":"2007","journal-title":"Nat Biotechnol"},{"issue":"4","key":"10.1016\/j.mehy.2009.09.003_bib3","doi-asserted-by":"crossref","first-page":"644","DOI":"10.1101\/gr.071852.107","article-title":"Protein networks in disease","volume":"18","author":"Ideker","year":"2008","journal-title":"Genome Res"},{"key":"10.1016\/j.mehy.2009.09.003_bib4","doi-asserted-by":"crossref","unstructured":"Ideker TE. Network genomics. Ernst Schering res found workshop, vol. 61; 2007. p. 89\u2013115.","DOI":"10.1007\/978-3-540-31339-7_5"},{"issue":"1","key":"10.1016\/j.mehy.2009.09.003_bib5","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1038\/nrd1609","article-title":"Multicomponent therapeutics for networked systems","volume":"4","author":"Keith","year":"2005","journal-title":"Nat Rev Drug Discov"},{"issue":"295","key":"10.1016\/j.mehy.2009.09.003_bib6","first-page":"40","article-title":"Embracing complexity, inching closer to reality","author":"Schadt","year":"2005","journal-title":"Sci STKE"},{"issue":"10","key":"10.1016\/j.mehy.2009.09.003_bib7","doi-asserted-by":"crossref","first-page":"1119","DOI":"10.1038\/nbt1338","article-title":"Drug-target network","volume":"25","author":"Yildirim","year":"2007","journal-title":"Nat Biotechnol"},{"issue":"13","key":"10.1016\/j.mehy.2009.09.003_bib8","doi-asserted-by":"crossref","first-page":"1102","DOI":"10.2174\/156802608785700016","article-title":"The hERG channel and risk of drug-acquired cardiac arrhythmia: an overview","volume":"8","author":"Lagrutta","year":"2008","journal-title":"Curr Top Med Chem"},{"issue":"4","key":"10.1016\/j.mehy.2009.09.003_bib9","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1038\/nrd1346","article-title":"Magic shotguns versus magic bullets: selectively non-selective drugs for mood disorders and schizophrenia","volume":"3","author":"Roth","year":"2004","journal-title":"Nat Rev Drug Discov"},{"issue":"2","key":"10.1016\/j.mehy.2009.09.003_bib10","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/j.pharmthera.2005.11.006","article-title":"Multi-target strategies for the improved treatment of depressive states: conceptual foundations and neuronal substrates, drug discovery and therapeutic application","volume":"110","author":"Millan","year":"2006","journal-title":"Pharmacol Ther"},{"issue":"7061","key":"10.1016\/j.mehy.2009.09.003_bib11","doi-asserted-by":"crossref","first-page":"942","DOI":"10.1038\/437942a","article-title":"Drug discovery: playing dirty","volume":"437","author":"Frantz","year":"2005","journal-title":"Nature"},{"issue":"8","key":"10.1016\/j.mehy.2009.09.003_bib12","doi-asserted-by":"crossref","first-page":"1083","DOI":"10.1016\/S0028-3908(99)00010-6","article-title":"A review of central 5-HT receptors and their function","volume":"38","author":"Barnes","year":"1999","journal-title":"Neuropharmacology"},{"issue":"2","key":"10.1016\/j.mehy.2009.09.003_bib13","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1007\/s12035-007-0006-1","article-title":"Modulation of ligand-gated ion channels by antidepressants and antipsychotics","volume":"35","author":"Rammes","year":"2007","journal-title":"Mol Neurobiol"},{"issue":"5","key":"10.1016\/j.mehy.2009.09.003_bib14","doi-asserted-by":"crossref","first-page":"951","DOI":"10.1016\/j.mehy.2007.09.012","article-title":"Non-serotonin anti-depressant actions: direct ion channel modulation by SSRIs and the concept of single agent poly-pharmacy","volume":"70","author":"Bianchi","year":"2008","journal-title":"Med Hypotheses"},{"issue":"1","key":"10.1016\/j.mehy.2009.09.003_bib15","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1177\/070674370204700106","article-title":"Atypical antipsychotics: mechanism of action","volume":"47","author":"Seeman","year":"2002","journal-title":"Can J Psychiatry"},{"issue":"5","key":"10.1016\/j.mehy.2009.09.003_bib16","doi-asserted-by":"crossref","first-page":"389","DOI":"10.2165\/00023210-200620050-00004","article-title":"Mechanism of action of atypical antipsychotic drugs and the neurobiology of schizophrenia","volume":"20","author":"Horacek","year":"2006","journal-title":"CNS Drugs"},{"issue":"11","key":"10.1016\/j.mehy.2009.09.003_bib17","doi-asserted-by":"crossref","first-page":"1039","DOI":"10.1016\/j.biopsych.2006.02.022","article-title":"Mechanisms of action of medicines for schizophrenia and bipolar illness: status and limitations","volume":"59","author":"Scolnick","year":"2006","journal-title":"Biol Psychiatry"},{"key":"10.1016\/j.mehy.2009.09.003_bib18","unstructured":"Meltzer HY. An overview of the mechanism of action of clozapine. J Clin Psychiatry 1994;55(Suppl B):47-52."},{"issue":"6","key":"10.1016\/j.mehy.2009.09.003_bib19","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1038\/nrd2571","article-title":"Schizophrenia therapy: beyond atypical antipsychotics","volume":"7","author":"Snyder","year":"2008","journal-title":"Nat Rev Drug Discov"},{"issue":"7","key":"10.1016\/j.mehy.2009.09.003_bib20","doi-asserted-by":"crossref","first-page":"1081","DOI":"10.1016\/j.pnpbp.2003.09.004","article-title":"Half a century of antipsychotics and still a central role for dopamine D2 receptors","volume":"27","author":"Kapur","year":"2003","journal-title":"Prog Neuropsychopharmacol Biol Psychiatry"},{"key":"10.1016\/j.mehy.2009.09.003_bib21","doi-asserted-by":"crossref","unstructured":"Laruelle M, Frankle WG, Narendran R, Kegeles LS, Abi-Dargham A. Mechanism of action of antipsychotic drugs: from dopamine D(2) receptor antagonism to glutamate NMDA facilitation. Clin Ther 2005;27(Suppl A):S16-24.","DOI":"10.1016\/j.clinthera.2005.07.017"},{"issue":"10","key":"10.1016\/j.mehy.2009.09.003_bib22","doi-asserted-by":"crossref","first-page":"1444","DOI":"10.1176\/ajp.152.10.1444","article-title":"D1, D2, and 5-HT2 receptor occupancy in relation to clozapine serum concentration: a PET study of schizophrenic patients","volume":"152","author":"Nordstrom","year":"1995","journal-title":"Am J Psychiatry"},{"issue":"Suppl 1","key":"10.1016\/j.mehy.2009.09.003_bib23","doi-asserted-by":"crossref","first-page":"S15","DOI":"10.1055\/s-2006-931484","article-title":"The complexity of the dopaminergic synapses and their modulation by antipsychotics","volume":"39","author":"Leuner","year":"2006","journal-title":"Pharmacopsychiatry"},{"issue":"1","key":"10.1016\/j.mehy.2009.09.003_bib24","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1016\/S0022-3565(24)37013-2","article-title":"Clozapine and haloperidol modulate N-methyl-D-aspartate- and non-N-methyl-D-aspartate receptor-mediated neurotransmission in rat prefrontal cortical neurons in vitro","volume":"283","author":"Arvanov","year":"1997","journal-title":"J Pharmacol Exp Ther"},{"issue":"1","key":"10.1016\/j.mehy.2009.09.003_bib25","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1016\/j.jchromb.2006.05.031","article-title":"Quantitative determination of forty-eight antidepressants and antipsychotics in human serum by HPLC tandem mass spectrometry: a multi-level, single-sample approach","volume":"843","author":"Kirchherr","year":"2006","journal-title":"J Chromatogr B Analyt Technol Biomed Life Sci"},{"issue":"6","key":"10.1016\/j.mehy.2009.09.003_bib26","doi-asserted-by":"crossref","first-page":"1547","DOI":"10.1038\/sj.bjp.0704608","article-title":"The effects of neuroleptics on the GABA-induced Cl- current in rat dorsal root ganglion neurons: differences between some neuroleptics","volume":"135","author":"Yokota","year":"2002","journal-title":"Br J Pharmacol"},{"issue":"5","key":"10.1016\/j.mehy.2009.09.003_bib27","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1016\/j.amjmed.2006.08.036","article-title":"Effective pharmacologic management of Alzheimer\u2019s disease","volume":"120","author":"Farlow","year":"2007","journal-title":"Am J Med"},{"issue":"9","key":"10.1016\/j.mehy.2009.09.003_bib28","doi-asserted-by":"crossref","first-page":"782","DOI":"10.1016\/S1474-4422(07)70195-3","article-title":"Efficacy and adverse effects of cholinesterase inhibitors and memantine in vascular dementia: a meta-analysis of randomised controlled trials","volume":"6","author":"Kavirajan","year":"2007","journal-title":"Lancet Neurol"},{"key":"10.1016\/j.mehy.2009.09.003_bib29","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1146\/annurev.med.57.121304.131442","article-title":"Current pharmacotherapy for Alzheimer\u2019s disease","volume":"57","author":"Lleo","year":"2006","journal-title":"Annu Rev Med."},{"key":"10.1016\/j.mehy.2009.09.003_bib30","doi-asserted-by":"crossref","unstructured":"McShane R, Areosa Sastre A, Minakaran N. Memantine for dementia. Cochrane Database Syst Rev. 2006(2):CD003154.","DOI":"10.1002\/14651858.CD003154.pub5"},{"issue":"6","key":"10.1016\/j.mehy.2009.09.003_bib31","doi-asserted-by":"crossref","first-page":"572","DOI":"10.1177\/1073858407305833","article-title":"The dichotomy of NMDA receptor signaling","volume":"13","author":"Papadia","year":"2007","journal-title":"Neuroscientist"},{"issue":"1","key":"10.1016\/j.mehy.2009.09.003_bib32","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/j.coph.2005.09.007","article-title":"Mechanism of action of memantine","volume":"6","author":"Johnson","year":"2006","journal-title":"Curr Opin Pharmacol"},{"issue":"2","key":"10.1016\/j.mehy.2009.09.003_bib33","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/0304-3940(95)11785-U","article-title":"Cerebrospinal fluid and serum concentrations of the N-methyl-D-aspartate (NMDA) receptor antagonist memantine in man","volume":"195","author":"Kornhuber","year":"1995","journal-title":"Neurosci Lett"},{"issue":"7","key":"10.1016\/j.mehy.2009.09.003_bib34","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1016\/0028-3908(95)00056-C","article-title":"Therapeutic brain concentration of the NMDA receptor antagonist amantadine","volume":"34","author":"Kornhuber","year":"1995","journal-title":"Neuropharmacology"},{"issue":"9","key":"10.1016\/j.mehy.2009.09.003_bib35","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1007\/s00228-006-0168-1","article-title":"Impact of the CYP2D6 polymorphism on steady-state plasma concentrations and clinical outcome of donepezil in Alzheimer\u2019s disease patients","volume":"62","author":"Varsaldi","year":"2006","journal-title":"Eur J Clin Pharmacol"},{"issue":"3","key":"10.1016\/j.mehy.2009.09.003_bib36","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1016\/j.mehy.2008.09.049","article-title":"From ion channels to complex networks: magic bullet versus magic shotgun approaches to anticonvulsant pharmacotherapy","volume":"72","author":"Bianchi","year":"2009","journal-title":"Med Hypotheses"},{"issue":"2","key":"10.1016\/j.mehy.2009.09.003_bib37","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1152\/jn.1989.61.2.363","article-title":"Trifluoperazine blocks GABA-gated chloride currents in cultured chick spinal cord neurons","volume":"61","author":"Yang","year":"1989","journal-title":"J Neurophysiol"},{"issue":"7","key":"10.1016\/j.mehy.2009.09.003_bib38","doi-asserted-by":"crossref","first-page":"2474","DOI":"10.1523\/JNEUROSCI.19-07-02474.1999","article-title":"Chlorpromazine inhibits miniature GABAergic currents by reducing the binding and by increasing the unbinding rate of GABAA receptors","volume":"19","author":"Mozrzymas","year":"1999","journal-title":"J Neurosci"},{"issue":"3","key":"10.1016\/j.mehy.2009.09.003_bib39","doi-asserted-by":"crossref","first-page":"957","DOI":"10.1006\/bbrc.1996.1278","article-title":"Functional antagonistic properties of clozapine at the 5-HT3 receptor","volume":"225","author":"Hermann","year":"1996","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1016\/j.mehy.2009.09.003_bib40","unstructured":"Rammes G, Eisensamer B, Ferrari U, Shapa M, Gimpl G, Gilling K, et al. Antipsychotic drugs antagonize human serotonin type 3 receptor currents in a noncompetitive manner. Mol Psychiatry. 2004;9(9):846-58,18."},{"issue":"4","key":"10.1016\/j.mehy.2009.09.003_bib41","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1007\/BF02071878","article-title":"Mutations in the M1 region of the nicotinic acetylcholine receptor alter the sensitivity to inhibition by quinacrine","volume":"15","author":"Tamamizu","year":"1995","journal-title":"Cell Mol Neurobiol"},{"issue":"6","key":"10.1016\/j.mehy.2009.09.003_bib42","doi-asserted-by":"crossref","first-page":"1541","DOI":"10.1016\/S0026-895X(25)09613-0","article-title":"Subtype-selective inhibition of N-methyl-D-aspartate receptors by haloperidol","volume":"50","author":"Ilyin","year":"1996","journal-title":"Mol Pharmacol"},{"issue":"3","key":"10.1016\/j.mehy.2009.09.003_bib43","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/S0304-3940(03)00523-8","article-title":"Clozapine inhibits isolated N-methyl-D-aspartate receptors expressed in xenopus oocytes in a subunit specific manner","volume":"346","author":"Levine","year":"2003","journal-title":"Neurosci Lett"},{"issue":"1","key":"10.1016\/j.mehy.2009.09.003_bib44","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1016\/j.brainres.2006.05.076","article-title":"The neuroleptic drug, fluphenazine, blocks neuronal voltage-gated sodium channels","volume":"1106","author":"Zhou","year":"2006","journal-title":"Brain Res"},{"issue":"3","key":"10.1016\/j.mehy.2009.09.003_bib45","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1016\/S0026-895X(25)08936-9","article-title":"Gate-dependent blockade of sodium channels by phenothiazine derivatives: structure-activity relationships","volume":"42","author":"Bolotina","year":"1992","journal-title":"Mol Pharmacol"},{"issue":"1","key":"10.1016\/j.mehy.2009.09.003_bib46","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1016\/0006-8993(89)91546-1","article-title":"Psychotropic drugs block voltage-gated ion channels in neuroblastoma cells","volume":"476","author":"Ogata","year":"1989","journal-title":"Brain Res"},{"issue":"4","key":"10.1016\/j.mehy.2009.09.003_bib47","doi-asserted-by":"crossref","first-page":"1848","DOI":"10.1152\/jn.00354.2006","article-title":"Inhibition of Nav1 7 and Nav1 4 sodium channels by trifluoperazine involves the local anesthetic receptor","volume":"96","author":"Sheets","year":"2006","journal-title":"J Neurophysiol"},{"issue":"2","key":"10.1016\/j.mehy.2009.09.003_bib48","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1016\/0006-8993(89)90607-0","article-title":"Effects of chlordiazepoxide, chlorpromazine, diazepam, diphenylhydantoin, flunitrazepam and haloperidol on the voltage-dependent sodium current of isolated mammalian brain neurons","volume":"494","author":"Wakamori","year":"1989","journal-title":"Brain Res"},{"issue":"19","key":"10.1016\/j.mehy.2009.09.003_bib49","doi-asserted-by":"crossref","first-page":"7513","DOI":"10.1073\/pnas.83.19.7513","article-title":"Neuroleptics of the diphenylbutylpiperidine series are potent calcium channel inhibitors","volume":"83","author":"Galizzi","year":"1986","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"1\u20132","key":"10.1016\/j.mehy.2009.09.003_bib50","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/S0014-2999(96)00500-6","article-title":"Inhibition by antipsychotic drugs of L-type Ca2+ channel current in PC12 cells","volume":"314","author":"Ito","year":"1996","journal-title":"Eur J Pharmacol"},{"issue":"2","key":"10.1016\/j.mehy.2009.09.003_bib51","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1111\/j.1476-5381.1994.tb14762.x","article-title":"Fluspirilene block of N-type calcium current in NGF-differentiated PC12 cells","volume":"111","author":"Grantham","year":"1994","journal-title":"Br J Pharmacol"},{"issue":"2","key":"10.1016\/j.mehy.2009.09.003_bib52","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1523\/JNEUROSCI.22-02-00396.2002","article-title":"Differential inhibition of T-type calcium channels by neuroleptics","volume":"22","author":"Santi","year":"2002","journal-title":"J Neurosci"},{"issue":"27","key":"10.1016\/j.mehy.2009.09.003_bib53","doi-asserted-by":"crossref","first-page":"16373","DOI":"10.1016\/S0021-9258(17)46233-8","article-title":"Blockade of low and high threshold Ca2+ channels by diphenylbutylpiperidine antipsychotics linked to inhibition of prolactin gene expression","volume":"265","author":"Enyeart","year":"1990","journal-title":"J Biol Chem"},{"issue":"4","key":"10.1016\/j.mehy.2009.09.003_bib54","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1046\/j.1365-201X.2001.00914.x","article-title":"Inhibition of human alpha1E subunit-mediated ca2+ channels by the antipsychotic agent chlorpromazine","volume":"173","author":"McNaughton","year":"2001","journal-title":"Acta Physiol Scand"},{"issue":"8","key":"10.1016\/j.mehy.2009.09.003_bib55","doi-asserted-by":"crossref","first-page":"960","DOI":"10.1038\/sj.bjp.0706017","article-title":"Inhibition of ATP-sensitive potassium channels by haloperidol","volume":"143","author":"Yang","year":"2004","journal-title":"Br J Pharmacol"},{"issue":"1","key":"10.1016\/j.mehy.2009.09.003_bib56","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/0014-2999(91)90569-C","article-title":"Chlorpromazine and related phenothiazines inhibit the ATP-sensitive K+ channel","volume":"198","author":"Muller","year":"1991","journal-title":"Eur J Pharmacol"},{"issue":"6","key":"10.1016\/j.mehy.2009.09.003_bib57","doi-asserted-by":"crossref","first-page":"1133","DOI":"10.1007\/s11095-006-0070-7","article-title":"Effects of antipsychotic drugs on I(to), I (Na), I (sus), I (K1), and hERG: QT prolongation, structure activity relationship, and network analysis","volume":"23","author":"Crumb","year":"2006","journal-title":"Pharm Res"},{"issue":"4","key":"10.1016\/j.mehy.2009.09.003_bib58","first-page":"1257","article-title":"Effects of haloperidol on K(+) currents in acutely isolated rat retinal ganglion cells","volume":"43","author":"Akamine","year":"2002","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"6","key":"10.1016\/j.mehy.2009.09.003_bib59","doi-asserted-by":"crossref","first-page":"676","DOI":"10.1016\/S0893-133X(00)00151-2","article-title":"Characterization of inhibition by risperidone of the inwardly rectifying K(+) current in pituitary GH(3) cells","volume":"23","author":"Wu","year":"2000","journal-title":"Neuropsychopharmacology"},{"issue":"2","key":"10.1016\/j.mehy.2009.09.003_bib60","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1016\/0014-2999(92)90360-G","article-title":"Blockade by trifluoperazine of a Ca(2+)-activated K+ channel in rat hippocampal pyramidal neurons","volume":"216","author":"Ikemoto","year":"1992","journal-title":"Eur J Pharmacol"},{"issue":"3","key":"10.1016\/j.mehy.2009.09.003_bib61","doi-asserted-by":"crossref","first-page":"1126","DOI":"10.1111\/j.1476-5381.1993.tb13931.x","article-title":"Block of potassium currents in rat isolated sympathetic neurones by tricyclic antidepressants and structurally related compounds","volume":"110","author":"Wooltorton","year":"1993","journal-title":"Br J Pharmacol"},{"key":"10.1016\/j.mehy.2009.09.003_bib62","doi-asserted-by":"crossref","unstructured":"Wible B, Murawsky MK, Crumb WJ, Jr., Rampe D. Stable expression and characterization of the human brain potassium channel Kv2.1: blockade by antipsychotic agents. Brain Res. 1997;761(1):42-50.","DOI":"10.1016\/S0006-8993(97)00315-6"},{"issue":"4","key":"10.1016\/j.mehy.2009.09.003_bib63","doi-asserted-by":"crossref","first-page":"1239","DOI":"10.1111\/j.1476-5381.1993.tb13755.x","article-title":"Differential inhibition of a transient K+ current by chlorpromazine and 4-aminopyridine in neurones of the rat dorsal root ganglia","volume":"109","author":"Ogata","year":"1993","journal-title":"Br J Pharmacol"},{"issue":"1","key":"10.1016\/j.mehy.2009.09.003_bib64","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1124\/jpet.105.086561","article-title":"Block of delayed-rectifier potassium channels by reduced haloperidol and related compounds in mouse cortical neurons","volume":"315","author":"Yang","year":"2005","journal-title":"J Pharmacol Exp Ther"},{"issue":"3","key":"10.1016\/j.mehy.2009.09.003_bib65","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1006\/bbrc.2001.5434","article-title":"The antipsychotic drugs sertindole and pimozide block erg3, a human brain K(+) channel","volume":"286","author":"Kang","year":"2001","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1016\/j.mehy.2009.09.003_bib66","doi-asserted-by":"crossref","unstructured":"Gomora JC, Enyeart JJ. Dual pharmacological properties of a cyclic AMP-sensitive potassium channel. J Pharmacol Exp Ther 1999;290(1):266-75.","DOI":"10.1016\/S0022-3565(24)34894-3"},{"issue":"1","key":"10.1016\/j.mehy.2009.09.003_bib67","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1016\/S0005-2736(96)00205-2","article-title":"Chlorpromazine activates chloride currents in Xenopus oocytes","volume":"1324","author":"Quamme","year":"1997","journal-title":"Biochim Biophys Acta"},{"issue":"1\u20132","key":"10.1016\/j.mehy.2009.09.003_bib68","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/S0304-3940(01)01872-9","article-title":"The N-methyl-D-aspartate receptor channel blockers memantine, MRZ 2\/579 and other amino-alkyl-cyclohexanes antagonise 5-HT(3) receptor currents in cultured HEK-293 and N1E\u2013115 cell systems in a non-competitive manner","volume":"306","author":"Rammes","year":"2001","journal-title":"Neurosci Lett"},{"issue":"7","key":"10.1016\/j.mehy.2009.09.003_bib69","doi-asserted-by":"crossref","first-page":"1313","DOI":"10.1038\/sj.bjp.0705559","article-title":"Inhibition of human alpha 7 nicotinic acetylcholine receptors by open channel blockers of N-methyl-D-aspartate receptors","volume":"140","author":"Maskell","year":"2003","journal-title":"Br J Pharmacol"},{"issue":"3","key":"10.1016\/j.mehy.2009.09.003_bib70","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1124\/mol.53.3.555","article-title":"Open-channel blockers at the human alpha4beta2 neuronal nicotinic acetylcholine receptor","volume":"53","author":"Buisson","year":"1998","journal-title":"Mol Pharmacol"},{"issue":"2","key":"10.1016\/j.mehy.2009.09.003_bib71","doi-asserted-by":"crossref","first-page":"834","DOI":"10.1016\/S0022-3565(24)36659-5","article-title":"Amantadine inhibits nicotinic acetylcholine receptor function in hippocampal neurons","volume":"281","author":"Matsubayashi","year":"1997","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1016\/j.mehy.2009.09.003_bib72","doi-asserted-by":"crossref","unstructured":"Oliver D, Ludwig J, Reisinger E, Zoellner W, Ruppersberg JP, Fakler B. Memantine inhibits efferent cholinergic transmission in the cochlea by blocking nicotinic acetylcholine receptors of outer hair cells. Mol Pharmacol. 200;60(1):183-9.","DOI":"10.1124\/mol.60.1.183"},{"issue":"2\u20133","key":"10.1016\/j.mehy.2009.09.003_bib73","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/j.ejphar.2004.12.037","article-title":"Cholinergic drugs potentiate human nicotinic alpha4beta2 acetylcholine receptors by a competitive mechanism","volume":"509","author":"Smulders","year":"2005","journal-title":"Eur J Pharmacol"},{"issue":"3","key":"10.1016\/j.mehy.2009.09.003_bib74","doi-asserted-by":"crossref","first-page":"1024","DOI":"10.1124\/jpet.102.045773","article-title":"Galantamine is an allosterically potentiating ligand of neuronal nicotinic but not of muscarinic acetylcholine receptors","volume":"305","author":"Samochocki","year":"2003","journal-title":"J Pharmacol Exp Ther"},{"issue":"10","key":"10.1016\/j.mehy.2009.09.003_bib75","doi-asserted-by":"crossref","first-page":"1239","DOI":"10.1016\/0028-3908(95)00092-K","article-title":"Comparison of the potency, kinetics and voltage-dependency of a series of uncompetitive NMDA receptor antagonists in vitro with anticonvulsive and motor impairment activity in vivo","volume":"34","author":"Parsons","year":"1995","journal-title":"Neuropharmacology"},{"issue":"1","key":"10.1016\/j.mehy.2009.09.003_bib76","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1097\/00000542-200101000-00024","article-title":"Effect of drugs used for neuropathic pain management on tetrodotoxin-resistant Na(+) currents in rat sensory neurons","volume":"94","author":"Brau","year":"2001","journal-title":"Anesthesiology"},{"issue":"3","key":"10.1016\/j.mehy.2009.09.003_bib77","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1111\/j.1472-8206.1998.tb00955.x","article-title":"Inhibitory effects of tacrine and physostigmine on catecholamine secretion and membrane currents in guinea-pig adrenal chromaffin cells","volume":"12","author":"Sugawara","year":"1998","journal-title":"Fundam Clin Pharmacol"},{"issue":"4","key":"10.1016\/j.mehy.2009.09.003_bib78","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1007\/s10517-006-0372-0","article-title":"Interaction of acetylcholinesterase inhibitor donepezil with ionic channels of the neuronal membrane","volume":"142","author":"Solntseva","year":"2006","journal-title":"Bull Exp Biol Med"},{"issue":"2","key":"10.1016\/j.mehy.2009.09.003_bib79","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1124\/jpet.107.122036","article-title":"Memantine inhibits ATP-dependent K+ conductances in dopamine neurons of the rat substantia nigra pars compacta","volume":"322","author":"Giustizieri","year":"2007","journal-title":"J Pharmacol Exp Ther"},{"issue":"5","key":"10.1016\/j.mehy.2009.09.003_bib80","doi-asserted-by":"crossref","first-page":"907","DOI":"10.1038\/sj.bjp.0705503","article-title":"Rivastigmine blocks voltage-activated K+ currents in dissociated rat hippocampal neurons","volume":"140","author":"Pan","year":"2003","journal-title":"Br J Pharmacol"}],"container-title":["Medical Hypotheses"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0306987709006082?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0306987709006082?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,2,12]],"date-time":"2025-02-12T11:18:44Z","timestamp":1739359124000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0306987709006082"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,2]]},"references-count":80,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2010,2]]}},"alternative-id":["S0306987709006082"],"URL":"https:\/\/doi.org\/10.1016\/j.mehy.2009.09.003","relation":{},"ISSN":["0306-9877"],"issn-type":[{"value":"0306-9877","type":"print"}],"subject":[],"published":{"date-parts":[[2010,2]]}}}